Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BRD7-IN-1, a modified derivative of BI7273 (BRD7/9 inhibitor), forms PROTAC VZ185 through linkage to a VHL ligand, demonstrating potent activity against BRD7/9 with DC50 values of 4.5 and 1.8 nM, respectively [1].
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 41,000 | |||
5 mg | 在庫あり | ¥ 104,500 | |||
10 mg | 在庫あり | ¥ 158,500 | |||
25 mg | 在庫あり | ¥ 303,000 | |||
50 mg | 在庫あり | ¥ 420,000 | |||
100 mg | 在庫あり | ¥ 567,000 |
説明 | BRD7-IN-1, a modified derivative of BI7273 (BRD7/9 inhibitor), forms PROTAC VZ185 through linkage to a VHL ligand, demonstrating potent activity against BRD7/9 with DC50 values of 4.5 and 1.8 nM, respectively [1]. |
分子量 | 467.39 |
分子式 | C22H28Cl2N4O3 |
CAS No. | 2448414-48-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 30 mg/mL (64.19 mM), Sonication is recommended.
H2O: 100 mg/mL (213.95 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BRD7-IN-1 2448414-48-8 Chromatin/Epigenetic Epigenetic Reader Domain Inhibitor BRD7IN1 BRD7 IN 1 BRD-7-IN-1 inhibit inhibitor